Evaluation of anti-diabetic attributes of Lactobacillus rhamnosus MTCC: 5957, Lactobacillus rhamnosus MTCC: 5897 and Lactobacillus fermentum MTCC: 5898 in streptozotocin induced diabetic rats.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Academic Press Country of Publication: England NLM ID: 8606191 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-1208 (Electronic) Linking ISSN: 08824010 NLM ISO Abbreviation: Microb Pathog Subsets: MEDLINE
    • Publication Information:
      Original Publication: London ; Orlando : Academic Press, c1986-
    • Subject Terms:
      Diabetes Mellitus, Experimental/*therapy ; Diet Therapy/*methods ; Limosilactobacillus fermentum/*metabolism ; Lacticaseibacillus rhamnosus/*metabolism ; Milk/*metabolism; Animals ; Blood Chemical Analysis ; Diabetes Mellitus, Type 1/therapy ; Disease Models, Animal ; Fermentation ; Kidney/pathology ; Limosilactobacillus fermentum/growth & development ; Lacticaseibacillus rhamnosus/growth & development ; Liver/pathology ; Milk/microbiology ; Rats, Wistar ; Treatment Outcome
    • Abstract:
      Interest in probiotics has grown significantly in the last decades due to their reported nutritional and health promoting effects. The aim of this study is to investigate the therapeutic potential of probiotic fermented milk (PFM) prepared using three different probiotic strains i.e. Lactobacillus rhamnosus MTCC: 5957, Lactobacillus rhamnosus MTCC: 5897 and Lactobacillus fermentum MTCC: 5898; independently or in combination, for treating streptozotocin induced type-1 diabetes in male Wistar rats. Diabetic rats were fed with PFM preparations for 6 weeks and then analyzed for the various biochemical parameters associated. The results indicated that feeding of PFM significantly improved glucose metabolism (fasting blood glucose, glycated hemoglobin, serum insulin), serum inflammation status (tumor necrosis factor-α, and serum interleukin-6), oxidative stress (thiobarbituric acid reactive substance, catalase, superoxide dismutase and glutathione peroxidase activities in liver and kidney), serum lipid profile (total cholesterol, low density lipoprotein-cholesterol, very low density lipoprotein-cholesterol, triglycerides) in diabetic rats. In addition, feeding of PFM has significantly reduced mRNA expression of pepck and g6pase genes that code the key enzymes of gluconeogenesis pathway. The results of this study showed that daily consumption of PFM can be effective in combating of type -1 diabetes and its complications.
      (Copyright © 2018 Elsevier Ltd. All rights reserved.)
    • Contributed Indexing:
      Keywords: Diabetes; Lactobacillus fermentum MTCC: 5898; Lactobacillus rhamnosus MTCC: 5897; Lactobacillus rhamnosus MTCC: 5957; Probiotics
    • Publication Date:
      Date Created: 20181014 Date Completed: 20190128 Latest Revision: 20221207
    • Publication Date:
      20231215
    • Accession Number:
      10.1016/j.micpath.2018.10.015
    • Accession Number:
      30316007